RWJBarnabas Health’s Post

Meet Dr Jason Chow, Consultant Medical Oncologist at Cromwell Hospital. Dr Jason Chow's main clinical interests are in treating patients with lung cancer, oesophageal and gastric cancers, and hepatobiliary and pancreatic cancers. He is part of Cromwell Hospital's non-specific symptoms pathway. "The most rewarding part of my specialty is supporting my patients, with my team, through their cancer journey. Every patient’s cancer journey is unique which is why it is so important to personalise and tailor their cancer treatment. Specialising in medical oncology helps me to achieve that goal." Find out more about Dr Chow in a personal interview: bit.ly/47rmKyC #CancerCare

🚨 Urgent Call for Review Comments! 🚨 Dear Experts in Precision Medicine and Oncology, I hope this message finds you well. We are currently seeking your valuable insights and urgent review comments on our latest manuscript titled "Progress in Precision Medicine in the Management of Gastric Cancer." This comprehensive study delves into the advancements in precision medicine and their transformative impact on the treatment and management of gastric cancer. Your expertise and feedback are crucial to ensuring the accuracy, relevance, and quality of this work. 📌 Key Focus Areas: Latest innovations in precision medicine for gastric cancer Case studies highlighting successful implementations Future perspectives and potential challenges. Please review the manuscript at your earliest convenience and provide your comments by [17 or 18 July 2024]. Your contributions will be instrumental in refining and enhancing this pivotal research.   Thank you for your time and expertise. Together, we can push the boundaries of medical research and improve patient outcomes in the fight against gastric cancer. Best regards, Nancy Grace Assistant Managing Editor #PrecisionMedicine #GastricCancer #OncologyResearch #MedicalInnovation #UrgentReview #PeerReview

Real-world data in lung cancer plays a key role in professing outcomes for our community. Worth joining this webinar from Lung Cancer Europe. Details below 👇

ASCO24, that's a wrap! - Thomas LeBlanc (Duke Cancer Institute) American Society of Clinical Oncology (ASCO) #oncodaily #oncology #cancer #ASCO2024 #ASCO24

Interested in the latest insights from oncologists ahead of #ASCO24? 🚀 Check out perspectives on this year's conference from the front lines of cancer care in our latest blog post: https://lnkd.in/eYupPznU #ASCO24 #OncologyInsights #HealthcareMarketResearch

Last Autumn, Jo Taylor founder of After Breast Cancer Diagnosis and METUPUK and Eva Schumacher from Mamma Mia, an online German cancer magazine, (Eva is a patient living with MBC), were asked to be involved in a campaign about “platitudes”. What you DON’T want to hear and what you DO want to hear from family members, friends, colleagues and even random strangers, when you are living with an incurable disease. The results of this work have been presented in a poster session at ESMO (European Society for Medical Oncology) Breast 248P this week and has won the best poster award! The findings were based on a survey of 249 people living with metastatic breast cancer. This report was initiated and funded by Seagen now part of Pfizer. You can read the poster via link here https://buff.ly/4aFiKwh #MetastaticMay #costofliving #severitymodifier #METUPUK #DarkerPink #BusyLivingWithMets #IAmThe31 #waitingroomfeet #BCAM #BreastCancer #BreastCancerCommunity #BreastCancerJourney #BreastCancerSupport #DyingForACure #EarlyDetectionSavesLives #MetastaticBreastCancerAwareness #SecondaryBreastCancer #SecondarySisters #Stage4NeedsMore #StageIVNeedsMore

Access to Clinical Trials for the Elderly with Cancer - Ishwaria Subbiah, MD, MS, FASCO American Society of Clinical Oncology (ASCO) The US Oncology Network Sarah Cannon Research Institute #ElderlyWithCancer #ASCO24 #Cancer #Oncology #OncoDaily #CancerResearch

Exciting News! "Questions For My Doctor" is now available in 16 additional languages! Download this crucial resource for patients with lobular breast cancer in conversations with their care teams. Thanks to the generous support of Daiichi Sankyo, we're making crucial information accessible worldwide. Explore the translations now: https://lnkd.in/gv3N3QeU #ILC #BreastCancerAwareness #PatientResources

Take advantage of free bowel cancer screening

The Multiple Myeloma Research Foundation - MMRF®has been leading cancer research for over 25 years, focused on multiple myeloma, the second most common blood cancer. By signing up for an MMRF Walk/Run event, you'll join nearly 30,000 participants nationwide to accelerate a cure. 'We remain committed to driving innovation through collaboration with our partners, and we will continue to do great things on behalf of myeloma patients everywhere,' states Michael Andreini, President and CEO of the Multiple Myeloma Research Foundation®. The MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring over 15 FDA-approved therapies to market, tripling the life expectancy of myeloma patients. With continued support, the MMRF will drive the development of next-generation therapies, identify optimal and personalized treatment approaches, and empower patients and the community with resources to extend their lives. Sari Cicurel #MultipleMyelomaAwareness #CancerResearch #AccelerateACure